Filter articles using the following links

ESGCT, Berlin, Germany

GenSight Biologics to Present Data on GS010 and GS030 at the 2017 Congress of the European Society of Gene & Cell Therapy

Chardan Inaugural Gene Therapy Conference, NYC (US)

GenSight Biologics to Attend Chardan Gene Therapy Conference

GenSight Biologics integrates the Enternext® PEA-PME 150 index

5th Annual Targeting Ocular Diseases, Boston (MA)

GenSight Biologics integrates the CAC® Small, CAC® Mid and Small and CAC® All-Tradable Euronext indexes

EUNOS, Budapest, Hungary

Ophthalmology Innovation Summit @ ASRS, Boston (MA)

GenSight Biologics Completes Enrollment of RESCUE Phase III Study of GS010 in the treatment of Leber’s Hereditary Optic Neuropathy